Ramakrishna Rachumallu

Dr. Ramakrishna Rachumallu

Simcyp (United Kingdom), Sheffield, UK
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Journal of Chromatography B
Verified
Journal Article
Closed access
MBManisha Bhateria
Manisha Bhateria
RRRamakrishna Rachumallu
Ramakrishna Rachumallu
DPDora Babu Pakala
Dora Babu Pakala
RBRabi Sankar Bhatta
Rabi Sankar Bhatta

21 January 2014 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
RSRAJBIR SINGH
RAJBIR SINGH
RRRamakrishna Rachumallu
Ramakrishna Rachumallu
MBManisha Bhateria
Manisha Bhateria
RBRabi Sankar Bhatta
Rabi Sankar Bhatta

31 May 2014 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
MBManisha Bhateria
Manisha Bhateria
RRRamakrishna Rachumallu
Ramakrishna Rachumallu
RSRAJBIR SINGH
RAJBIR SINGH
RBRabi Sankar Bhatta
Rabi Sankar Bhatta
Erythrocytes (red blood cells [RBCs]) and artificial or synthetic delivery systems such as liposomes, nanoparticles (NPs) are the most investigated carrier systems. Herein, progress made from conventional approach of using RBC as delivery systems to novel approach of using synthetic delivery systems based on RBC properties will be reviewed. We aim to highlight both conventional and novel approaches of using RBCs as potential carrier system. Conventional approaches which include two main strategies are: i) directly loading therapeutic moieties in RBCs; and ii) coupling them with RBCs whereas novel approaches exploit structural, mechanical and biological properties of RBCs to design synthetic delivery systems through various engineering strategies. Initial attempts included coupling of antibodies to liposomes to specifically target RBCs. Knowledge obtained from several studies led to the development of RBC membrane derived liposomes (nanoerythrosomes), inspiring future application of RBC or its structural features in other attractive delivery systems (hydrogels, filomicelles, microcapsules, micro- and NPs) for even greater potential. In conclusion, this review dwells upon comparative analysis of various conventional and novel engineering strategies in developing RBC based drug delivery systems, diversifying their applications in arena of drug delivery. Regardless of the challenges in front of us, RBC based delivery systems offer an exciting approach of exploiting biological entities in a multitude of medical applications.

1 April 2016 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
NMNaresh Mittapelly
Naresh Mittapelly
RRRamakrishna Rachumallu
Ramakrishna Rachumallu
GPGitu Pandey
Gitu Pandey
SSShweta Sharma
Shweta Sharma
AAAbhishek Arya
Abhishek Arya
PMPrabhat Ranjan Mishra
Prabhat Ranjan Mishra

1 May 2015 in Journal of Chromatography B
Verified
Journal Article
Closed access
RRRamakrishna Rachumallu
Ramakrishna Rachumallu
SPSantosh Kumar Puttrevu
Santosh Kumar Puttrevu
MBManisha Bhateria
Manisha Bhateria
VBVeenu Bala
Veenu Bala
VSVishnu L. Sharma
Vishnu L. Sharma
RBRabi Sankar Bhatta
Rabi Sankar Bhatta

1 June 2016 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
RRRamakrishna Rachumallu
Ramakrishna Rachumallu
MBManisha Bhateria
Manisha Bhateria
RSRAJBIR SINGH
RAJBIR SINGH
SPSantosh Puttrevu
Santosh Puttrevu
RBRabi Sankar Bhatta
Rabi Sankar Bhatta